Decheng Capital LLC Portfolio Holdings

Decheng Capital LLC

  • $326 Billion
  • Q2 2024

Decheng Capital LLC has filed its 13F form on August 14, 2024 for Q2 2024 where it was disclosed a total value porftolio of $326 Billion distributed in 24 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Cg Oncology Inc with a value of $172B, Nuvation Bio Inc. with a value of $20.3B, Arcus Biosciences, Inc. with a value of $13.2B, Zentalis Pharmaceuticals, Inc. with a value of $12.6B, and Krystal Biotech, Inc. with a value of $12.1B.

Examining the 13F form we can see an decrease of $419B in the current position value, from $746B to 326B.

Decheng Capital LLC is based out at Menlo Park, CA

Below you can find more details about Decheng Capital LLC portfolio as well as his latest detailed transactions.

Portfolio value $326 Billion
Healthcare: $136 Billion

Stock Holdings Table Market Cap. of Under $50 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$28.9M
$3.08 Billion 0.94% of portfolio
4,447,308
Q4 2023 New

Summary

  • Portfolio
  • No. of Stocks 24
  • Current Value $326 Billion
  • Prior Value $746 Billion
  • Filing
  • Period Q2 2024
  • Filing Date August 14, 2024
  • Form Type 13F-HR
  • Activity in Q2 2024
  • New Purchases 6 stocks
  • Additional Purchases 3 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 1 stocks
Track This Portfolio

Track Decheng Capital LLC Portfolio

Follow Decheng Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Decheng Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Decheng Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email